TO STUDY EFFECTIVENESS OF MICROPULSE LASER IN DIABETIC MACULAR EDEMA

Evaluating The Efficacy of Subthreshold Micropulse focal Laser in Non Centre involving Clinically significant Diabetic Macular Edema - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056275

Enrollment

Registered

2023-08-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: Subthreshold Micropulse focal yellow laser(577): Subthreshold Micropulse focal yellow laser (577nm)to be done on Ten eyes of Non centre involving Clinically significant Diabetic macular

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with non centre involving Clinically significant Diabetic macular Edema 2.Central Macular Thickness on OCT 3.Patient willing to give Informed Consent 4.Patient willing to come for follow ups

Exclusion criteria

Exclusion criteria: 1.Central Macular thickness >350microns 2.Retinal disorder other than Diabetic Retinopathy 3.Associated Glaucoma 4.Unwilling to give consent

Design outcomes

Primary

Measure	Time frame
1.Change in Macular Volume 2.Change in Macular thickness of 3mm & 6mm zones of ETDRS gridTimepoint: 1month, 3month & 6month	—

Secondary

Measure	Time frame
1.Change in density of Hard exudates assessed using Image J. 2.Conversion of non centre involving Edema to Centre involving Edema. 3.Change in best corrected visual acuity Timepoint: 1month,3month & 6month	—

Countries

India

Contacts

Public ContactDr Swati Sharma

Dr Rajendra Prasad Centre for Ophthalmic Sciences

dr.rohanrpc@gmail.com9891052939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026